|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/1/19 Lineage Cell Therapeutics, Inc. 10-K/A 12/31/18 3:69K M2 Compliance LLC/FA
4/30/19 Lineage Cell Therapeutics, Inc. 10-K/A 12/31/18 5:829K M2 Compliance LLC/FA
3/14/19 Lineage Cell Therapeutics, Inc. 10-K 12/31/18 102:9.3M M2 Compliance LLC/FA
2/14/19 Kingsley Alfred D 5 Director² 1:5K Lineage Cell Therapeutics, Inc. DONNELLEY FIN… File16/FA
____________ | ¹ | Filing/Form Types: -K | | 5 | Annual Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 5 { The Filer is an Insider² of the Issuer }. | | 10-K | Annual Report — Form 10-K. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|